Increase in Tablo Console Sales
Tablo console sales increased by 8% in the third quarter, reflecting growing hospital demand and an expanded sales pipeline with opportunities increasing in size by more than 20%.
Improved Gross Margin
Non-GAAP gross margin expanded by 350 basis points year-over-year, reaching 39.9%, with product gross margin increasing to 45.7% and service margin more than doubling to 24.8%.
Strong Cash Position and Reduced Cash Use
Ended the quarter with $182 million in cash and a significant reduction in cash use by more than 50% from 2024, projecting less than $50 million used in 2025.
Positive Clinical Outcomes
Presented three new data sets at the Annual Kidney Week Conference, including a 94% reduction in serious cardiac or respiratory events and a sustained reduction in infections at AdventHealth.